News

Development of pain-reducing electrical stimulation device, opening up new medical technology

Shin, Jae-Yoo Reporter from Sports Seoul] KOIBIG (CEO Yoo Seung-gu), a medical device development and manufacturing company, is making headlines by opening a new path to chronic pain treatment. The company developed "Pain Block," a pain-reducing percutaneous electrical stimulation device that uses state-of-the-art neuron medical technology which is safe for the human body to treat pain non-surgically without injections or drugs has secured intellectual property rights.
 



 

[Shin, Jae-Yoo Reporter from Sports Seoul] KOIBIG (CEO Yoo Seung-gu), a medical device development and manufacturing company, is making headlines by opening a new path to chronic pain treatment. The company developed "Pain Block," a pain-reducing percutaneous electrical stimulation device that uses state-of-the-art neuron medical technology which is safe for the human body to treat pain non-surgically without injections or drugs has secured intellectual property rights.

The device is nothing like the treatments that block the path of pain, but an innovative neural information control system that artificially normalizes the properties of the nociceptive system to eliminate pain.

The 'Pain block' treatment consists of an adhesive pad. When electrodes are placed in a pain-causing position and the device is operated, a pain-free signal is generated with a soft but strong output, which is passed to the brain, and the patient recognizes the pain signal as pain-free.

This neural information control technology can help patients with chronic, cancer, and incurable pain, such as acute pain after surgery and post-traumatic pain, pain after treatment, and nerve pain, which is difficult to obtain pain relief from existing pain treatments.

KOIBIG, which increased the possibility of value-increase in the high-end technology industry through "Pain Block," has been granted an item license of non-payment code MZ012 for its non-invasive painless signal therapy by the Ministry of Food and Drug Safety and GMP certification.

It was well-received for showcasing "Pain Block" at 'KIMES Busan 2018', Korea's largest exhibition specializing in specialized medical devices in South and North Gyeongsang provinces, at BEXCO in Busan, and is also planning to participate in the 2019 KIMES exhibition this year.

With four employees with more than 10 years of experience in medical device development, including CEO Yoo Seung-koo with 14 years of experience, KOIBIG plans to develop wearable devices, personal medical devices incorporating IoT and beauty devices in the future. ‘“Pain block'' will be an appropriate response to pain-related illnesses, which increase by more than 10 percent each year,’ Yoo said.

whyjay@sportsseoul.com

View original text:
http://www.sportsseoul.com/news/read/733393#csidx5fc89c618fef64595bb1437d0c49899
koibig2 koibig2 · 2019-03-16 19:25 · Views 214
Close Menu